A PYMNTS Company

US: FTC announces forum on pharmaceutical competition

By  |  November 10, 2013

The US Federal Trade Commission announced Friday it plans to hold a public workshop next month to discuss the current state of competition within the pharmaceutical sector and how state regulation impacts the market.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    According to the FTC, the regulator is hearing concerns that recent state-level legislation could raise barriers for the development of lower-cost biologics, which are used to target difficult-to-treat diseases and represent the fastest growing aspect of the pharmaceutical industry.

    The workshop, to be held December 10 in Washington, D.C., will look at how state legislation has affected the market.

    Full Content: EIN Newsdeck

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.